>
NeuPath Health Inc logo

NPTH - NeuPath Health Inc Share Price

C$0.6 0.0  0.0%

Last Trade - 27/10/21

Sector
Healthcare
Size
Micro Cap
Market Cap £15.9m
Enterprise Value £22.5m
Revenue £32.3m
Position in Universe 1440th / 2696
Bullish
Bearish
Unlock NPTH Revenue
Momentum
Relative Strength (%)
1m +3.94%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -43.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 13.5 40.2 49.6 47.6 66.0 106 +52.4%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2021, NeuPathHealth Inc revenues increased 32% to C$30.1M. Net lossdecreased 56% to C$1.9M. Revenues reflect Clinic revenuesegment increase of 39% to C$28.8M. Lower net loss reflectsListing expense and transaction costs decrease of 76% toC$540K (expense), Interest cost decrease of 88% to C$101K(expense). Basic Earnings per Share excluding ExtraordinaryItems increased from -C$0.23 to -C$0.04.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

NPTH Revenue Unlock NPTH Revenue

Net Income

NPTH Net Income Unlock NPTH Revenue

Normalised EPS

NPTH Normalised EPS Unlock NPTH Revenue

PE Ratio Range

NPTH PE Ratio Range Unlock NPTH Revenue

Dividend Yield Range

NPTH Dividend Yield Range Unlock NPTH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
NPTH EPS Forecasts Unlock NPTH Revenue
Profile Summary

NeuPath Health Inc (NeuPath), formerly Klinik Health Ventures Corp, is a Canada-based company that provides chronic pain management services. The Company operates under the brand names: Centres for Pain Management (CPM) and InMedic Creative Medicine (InMedic) in Ontario. NeuPath offers chronic pain assessment and multi-modal treatment plan based on recommendations by a group of physicians to help patients manage their chronic pain. In addition to chronic pain management clinics, NeuPath offers workplace health services and independent medical assessments to disability insurers through its subsidiary, CompreMed Canada Inc. NeuPath has approximately 12 locations across Ontario with more than 100 licensed healthcare providers. The Company also operates a facility in Edmonton, offering physician-based care services for a wide range of injuries and issues, including spinal injuries, sport medicine, and concussions.

Directors
Last Annual December 31st, 2020
Last Interim June 30th, 2021
No. of Shareholders: n/a
No. of Employees: 110
Sector Healthcare
Industry Healthcare Providers & Services
Index
Exchange TSX Venture Exchange
Shares in Issue 45,068,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
NPTH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for NPTH
Upcoming Events for NPTH
Frequently Asked Questions for NeuPath Health Inc
What is the NeuPath Health Inc share price?

As of 27/10/21, shares in NeuPath Health Inc are trading at C$0.6, giving the company a market capitalisation of £15.9m. This share price information is delayed by 15 minutes.

How has the NeuPath Health Inc share price performed this year?

Shares in NeuPath Health Inc are currently trading at C$0.6 and the price has moved by -36.84% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the NeuPath Health Inc price has moved by -53.51% over the past year.

What are the analyst and broker recommendations for NeuPath Health Inc?

There are no analysts currently covering NeuPath Health Inc.

When will NeuPath Health Inc next release its financial results?

NeuPath Health Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-06-30
What is the NeuPath Health Inc dividend yield?

NeuPath Health Inc does not currently pay a dividend.

Does NeuPath Health Inc pay a dividend?

NeuPath Health Inc does not currently pay a dividend.

When does NeuPath Health Inc next pay dividends?

NeuPath Health Inc does not currently pay a dividend.

How do I buy NeuPath Health Inc shares?

To buy shares in NeuPath Health Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of NeuPath Health Inc?

Shares in NeuPath Health Inc are currently trading at C$0.6, giving the company a market capitalisation of £15.9m.

Where are NeuPath Health Inc shares listed? Where are NeuPath Health Inc shares listed?

Here are the trading details for NeuPath Health Inc:

Country of listing: Canada
Exchange: CVE
Ticker Symbol: NPTH
What kind of share is NeuPath Health Inc?

Based on an overall assessment of its quality, value and momentum, NeuPath Health Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a NeuPath Health Inc share price forecast 2021?

Shares in NeuPath Health Inc are currently priced at C$0.6. At that level they are trading at 58.33% discount to the analyst consensus target price of 0.00.

Analysts covering NeuPath Health Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.03 for the next financial year.

How can I tell whether the NeuPath Health Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like NeuPath Health Inc. Over the past six months, the relative strength of its shares against the market has been -21.09%. At the current price of C$0.6, shares in NeuPath Health Inc are trading at -9.28% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the NeuPath Health Inc PE Ratio?

We were not able to find PE ratio data for NeuPath Health Inc.

Who are the key directors of NeuPath Health Inc?

We were unable to find the directors for NeuPath Health Inc.

Who are the major shareholders of NeuPath Health Inc?

Here are the top five shareholders of NeuPath Health Inc based on the size of their shareholding:

Claret Asset Management Corporation Investment Advisor
Percentage owned: 13.41% (6.05m shares)
Ram (Grishanth) Individual Investor
Percentage owned: 10.41% (4.69m shares)
Bloom Burton & Co. Inc. Research Firm
Percentage owned: 9.82% (4.43m shares)
Healthcare Special Opportunities Fund Mutual Fund
Percentage owned: 1.31% (591k shares)
LDIC Inc. Investment Advisor
Percentage owned: 1.31% (591k shares)
Similar to NPTH
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.